No Regular Interest; Accrual and Payment of Special Interest and Additional Interest. Defaulted Amounts; When Payment Date is Not a Business Day 17 Section 2.06. Registrar, Paying Agent and Conversion Agent 18 Section 2.07. Paying Agent and Conversion Agent to Hold Property in Trust 19 Section 2.08. Holder Lists 20 Section 2.09. Legends 20 Section 2.10. Transfers and Exchanges; Certain Transfer Restrictions 21 Section 2.11. Exchange and Cancellation of Notes to Be Converted or to Be Repurchased Pursuant to a Repurchase Upon Fundamental Change or Redemption 26 Section 2.12. Replacement Notes 27 Section 2.13. Registered Holders; Certain Rights with Respect to Global Notes 27 Section 2.14. Cancellation 27 Section 2.15. Notes Held by the Company or its Affiliates 27 Section 2.16. Temporary Notes 28 Section 2.17. Outstanding Notes 28 Section 2.18. Repurchases by the Company 29 Section 2.19. ▇▇▇▇▇ and ISIN Numbers 29 Article 3. Covenants 29 Section 3.01. Payment on Notes 29 Section 3.02. Exchange Act Reports 29 Section 3.03. Rule 144A Information 30 Section 3.04. Additional Interest 30 Section 3.05. Compliance and Default Certificates 31 Section 3.06. Stay, Extension and Usury Laws 31 Section 3.07. Corporate Existence 32 Section 3.08. Acquisition of Notes by the Company and its Affiliates 32 Article 4. Repurchase and Redemption 32 Section 4.01. No Sinking Fund 32 Section 4.02. Right of Holders to Require the Company to Repurchase Notes Upon a Fundamental Change 32 Section 4.03. Right of the Company to Redeem the Notes 37 Article 5. The Conversion of Notes 40 Section 5.01. Right to Convert 40 Section 5.02. Conversion Procedures 44 Section 5.03. Settlement Upon Conversion 45 Section 5.04. Reserve and Status of Common Stock Issued Upon Conversion 49 Section 5.05. Adjustments to the Conversion Rate 50 Section 5.06. Voluntary Adjustments 60 Section 5.07. Adjustments to the Conversion Rate in Connection with a Make-Whole Fundamental Change 61 Section 5.08. Exchange in Lieu of Conversion 62 Section 5.09. Effect of Common Stock Change Event 62 Article 6. Successors 64 Section 6.01. When the Company May Merge, Etc. 64 Section 6.02. Successor Entity Substituted 65 Section 6.03. Exclusion for Asset Transfers with Wholly Owned Subsidiaries 65 Article 7. Defaults and Remedies 65 Section 7.01. Events of Default 65 Section 7.02. Acceleration 67 Section 7.03. Sole Remedy for a Failure to Report 68 Section 7.04. Other Remedies 69 Section 7.05. Waiver of Past Defaults 69 Section 7.06. Cure of Defaults; Ability to Cure or Waive Before Event of Default Occurs 69 Section 7.07. Control by Majority 70 Section 7.08. Limitation on Suits 70 Section 7.09. Absolute Right of Holders to Institute Suit for the Enforcement of the Right to Receive Payment and Conversion Consideration 70 Section 7.10. Collection Suit by Trustee 71 Section 7.11. Trustee May File Proofs of Claim 71 Section 7.12. Priorities 71 Section 7.13. Undertaking for Costs 72 Article 8. Amendments, Supplements and Waivers 72 Section 8.01. Without the Consent of Holders 72 Section 8.02. With the Consent of Holders 73 Section 8.03. Notice of Amendments, Supplements and Waivers 74 Section 8.04. Revocation, Effect and Solicitation of Consents; Special Record Dates; Etc. 74 Section 8.05. Notations and Exchanges 75 Section 8.06. Trustee to Execute Supplemental Indentures 75 Article 9. Satisfaction and Discharge 75 Section 9.01. Termination of Company’s Obligations 75 Section 9.02. Repayment to Company 76 Section 9.03. Reinstatement 76 Article 10. Trustee 76 Section 10.01. Duties of the Trustee 76 Section 10.02. Rights of the Trustee 77 Section 10.03. Individual Rights of the Trustee 79 Section 10.04. Trustee’s Disclaimer 79 Section 10.05. Notice of Defaults 79 Section 10.06. Compensation and Indemnity 79 Section 10.07. Replacement of the Trustee 80 Section 10.08. Successor Trustee by Merger, Etc. 81 Section 10.09. Eligibility; Disqualification 81 Article 11. Miscellaneous 82 Section 11.01. Notices 82 Section 11.02. Delivery of Officer’s Certificate and Opinion of Counsel as to Conditions Precedent 83 Section 11.03. Statements Required in Officer’s Certificate and Opinion of Counsel 84 Section 11.04. Rules by the Trustee, the Registrar, the Paying Agent and the Conversion Agent 84 Section 11.05. No Personal Liability of Directors, Officers, Employees and Stockholders 84 Section 11.06. Governing Law; Waiver of Jury Trial 84 Section 11.07. Submission to Jurisdiction 85 Section 11.08. No Adverse Interpretation of Other Agreements 85 Section 11.09. Successors 85 Section 11.10. Force Majeure 85 Section 11.11. U.S.A. PATRIOT Act 85 Section 11.12. Calculations 85 Section 11.13. Severability 86 Section 11.14. Counterparts 86 Section 11.15. Table of Contents, Headings, Etc. 86 Section 11.16. Withholding Taxes 86 Exhibit A: Form of Note A-1 Exhibit B-1: Form of Restricted Note Legend B1-1 Exhibit B-2: Form of Global Note Legend B2-1 Exhibit B-3: Form of Non-Affiliate Legend B3-1 INDENTURE, dated as of May 13, 2025, between Hims & Hers Health, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). Each party to this Indenture (as defined below) agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders (as defined below) of the Company’s 0.00% Convertible Senior Notes due 2030 (the “Notes”).
Appears in 1 contract
Sources: Indenture (Hims & Hers Health, Inc.)
No Regular Interest; Accrual and Payment of Special Interest and Additional Interest. Defaulted Amounts; When Payment Date is Not a Business Day 17 16 Section 2.06. Registrar, Paying Agent and Conversion Agent 18 17 Section 2.07. Paying Agent and Conversion Agent to Hold Property in Trust 19 18 Section 2.08. Holder Lists 20 18 Section 2.09. Legends 20 19 Section 2.10. Transfers and Exchanges; Certain Transfer Restrictions 21 20 Section 2.11. Exchange and Cancellation of Notes to Be Converted or to Be Repurchased Pursuant to a Repurchase Upon Fundamental Change or Redemption 26 24 Section 2.12. Removal of Transfer Restrictions 25 Section 2.13. Replacement Notes 27 26 Section 2.132.14. Registered Holders; Certain Rights with Respect to Global Notes 27 26 Section 2.142.15. Cancellation 27 26 Section 2.152.16. Notes Held by the Company or its Affiliates 27 26 Section 2.162.17. Temporary Notes 28 27 Section 2.172.18. Outstanding Notes 28 27 Section 2.182.19. Repurchases by the Company 29 28 Section 2.192.20. ▇▇▇▇▇ CUSIP and ISIN Numbers 29 28 Article 3. Covenants 29 28 Section 3.01. Payment on Notes 29 28 Section 3.02. Exchange Act Reports 29 28 Section 3.03. Rule 144A Information 30 29 Section 3.04. Additional Interest 30 29 Section 3.05. Compliance and Default Certificates 31 30 Section 3.06. Stay, Extension and Usury Laws 31 30 Section 3.07. Corporate Existence 32 31 Section 3.08. Acquisition of Notes by the Company and its Affiliates 32 31 Section 3.09. Further Instruments and Acts 31 Article 4. Repurchase and Redemption 32 31 Section 4.01. No Sinking Fund 32 31 Section 4.02. Right of Holders to Require the Company to Repurchase Notes Upon a Fundamental Change 32 31 Section 4.03. Right of the Company to Redeem the Notes 37 36 Article 5. The Conversion of Notes 40 39 Section 5.01. Right to Convert 40 39 Section 5.02. Conversion Procedures 44 42 Section 5.03. Settlement Upon Conversion 45 44 Section 5.04. Reserve and Status of Common Stock Issued Upon Conversion 49 47 Section 5.05. Adjustments to the Conversion Rate 50 48 Section 5.06. Voluntary Adjustments 60 58 Section 5.07. Adjustments to the Conversion Rate in Connection with a Make-Whole Fundamental Change 61 58 Section 5.08. Exchange in Lieu of Conversion 62 60 Section 5.09. Effect of Common Stock Change Event 61 Section 5.10. Responsibility of Trustee 62 Article 6. Successors 64 63 Section 6.01. When the Company May Merge, Etc. 64 63 Section 6.02. Successor Entity Corporation Substituted 65 64 Section 6.03. Exclusion for Asset Transfers with Wholly Owned Subsidiaries 65 64 Article 7. Defaults and Remedies 65 64 Section 7.01. Events of Default 65 64 Section 7.02. Acceleration 67 66 Section 7.03. Sole Remedy for a Failure to Report 68 67 Section 7.04. Other Remedies 69 68 Section 7.05. Waiver of Past Defaults 69 68 Section 7.06. Cure of Defaults; Ability to Cure or Waive Before Event of Default Occurs 69 Section 7.07. Control by Majority 70 68 Section 7.087.07. Limitation on Suits 70 69 Section 7.097.08. Absolute Right of Holders to Institute Suit for the Enforcement of the Right to Receive Payment and Conversion Consideration 70 69 Section 7.107.09. Collection Suit by Trustee 71 69 Section 7.117.10. Trustee May File Proofs of Claim 71 70 Section 7.11. Priorities 70 Section 7.12. Priorities 71 Section 7.13. Undertaking for Costs 72 71 Article 8. Amendments, Supplements and Waivers 72 71 Section 8.01. Without the Consent of Holders 72 71 Section 8.02. With the Consent of Holders 73 72 Section 8.03. Notice of Amendments, Supplements and Waivers 74 73 Section 8.04. Revocation, Effect and Solicitation of Consents; Special Record Dates; Etc. 74 Etc 73 Section 8.05. Notations and Exchanges 75 74 Section 8.06. Trustee to Execute Supplemental Indentures 75 74 Article 9. Satisfaction and Discharge 75 Section 9.01. Termination of Company’s Obligations 75 Section 9.02. Repayment to Company 76 75 Section 9.03. Reinstatement 76 Article 10. Trustee 76 Section 10.01. Duties of the Trustee 76 Section 10.02. Rights of the Trustee 77 Section 10.03. Individual Rights of the Trustee 79 78 Section 10.04. Trustee’s Disclaimer 79 78 Section 10.05. Notice of Defaults 79 Section 10.06. Compensation and Indemnity 79 Section 10.07. Replacement of the Trustee 80 Section 10.08. Successor Trustee by Merger, Etc. Etc 81 Section 10.09. Eligibility; Disqualification 81 Article 11. Miscellaneous 82 81 Section 11.01. Notices 82 81 Section 11.02. Delivery of Officer’s Certificate and Opinion of Counsel as to Conditions Precedent 83 84 Section 11.03. Statements Required in Officer’s Certificate and Opinion of Counsel 84 Section 11.04. Rules by the Trustee, the Registrar, Registrar and the Paying Agent and the Conversion Agent 84 Section 11.05. No Personal Liability of Directors, Officers, Employees and Stockholders 84 Section 11.06. Governing Law; Waiver of Jury Trial 84 85 Section 11.07. Submission to Jurisdiction 85 Section 11.08. No Adverse Interpretation of Other Agreements 85 Section 11.09. Successors 85 Section 11.10. Force Majeure 85 Section 11.11. U.S.A. PATRIOT Act 85 86 Section 11.12. Calculations 85 86 Section 11.13. Severability 86 Section 11.14. Counterparts 86 Section 11.15. Table of Contents, Headings, Etc. 86 Section 11.16. Withholding Taxes 86 Exhibit A: Form of Note A-1 Exhibit B-1▇-▇ ▇▇▇▇▇▇▇ ▇-▇: Form of Restricted Note Legend B1-1 Exhibit B-2: Form of Global Note Legend B2-1 2 Exhibit B-3: Form of Non-Affiliate Legend B3-1 INDENTURE, dated as of May 13December 18, 20252020, between Hims & Hers HealthVail Resorts, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). Each party to this Indenture (as defined below) agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders (as defined below) of the Company’s 0.00% Convertible Senior Notes due 2030 2026 (the “Notes”).
Appears in 1 contract
Sources: Indenture (Vail Resorts Inc)
No Regular Interest; Accrual and Payment of Special Interest and Additional Interest. Defaulted Amounts; When Payment Date is Not a Business Day 17 Section 2.06. Registrar, Paying Agent and Conversion Agent 18 19 Section 2.07. Paying Agent and Conversion Agent to Hold Property in Trust 19 20 Section 2.08. Holder Lists 20 Section 2.09. Legends 20 Section 2.10. Transfers and Exchanges; Certain Transfer Restrictions 21 Section 2.11. Exchange and Cancellation of Notes to Be Converted or to Be Repurchased Pursuant to a Repurchase Upon Fundamental Change Change, Optional Repurchase or Redemption 26 Section 2.12. Removal of Transfer Restrictions 27 Section 2.13. Replacement Notes 27 Section 2.132.14. Registered Holders; Certain Rights with Respect to Global Notes 27 28 Section 2.142.15. Cancellation 27 28 Section 2.152.16. Notes Held by the Company or its Affiliates 27 Section 2.16. Temporary Notes 28 Section 2.17. Temporary Notes 29 Section 2.18. Outstanding Notes 28 29 Section 2.182.19. Repurchases by the Company 29 30 Section 2.192.20. ▇▇▇▇▇ CUSIP and ISIN Numbers 29 30 Article 3. Covenants 29 30 Section 3.01. Payment on Notes 29 30 Section 3.02. Exchange Act Reports 29 30 Section 3.03. Rule 144A Information 30 31 Section 3.04. Additional Interest 30 31 Section 3.05. Compliance and Default Certificates 31 33 Section 3.06. Stay, Extension and Usury Laws 31 34 Section 3.07. Corporate Existence 32 Section 3.08. Acquisition of Notes by the Company and its Affiliates 32 34 Section 3.08. Existence 34 Article 4. Repurchase and Redemption 32 34 Section 4.01. No Sinking Fund 32 34 Section 4.02. Right of Holders to Require the Company to Repurchase Notes Upon a Fundamental Change 32 34 Section 4.03. Right of Holders to Require the Company to Repurchase Notes on the Optional Repurchase Date 39 Section 4.04. Right of the Company to Redeem the Notes 37 43 Article 5. The Conversion of Notes 40 46 Section 5.01. Right to Convert 40 46 Section 5.02. Conversion Procedures 44 50 Section 5.03. Settlement Upon Conversion 45 52 Section 5.04. Reserve and Status of Class A Common Stock Issued Upon Conversion 49 56 Section 5.05. Adjustments to the Conversion Rate 50 57 Section 5.06. Voluntary Adjustments 60 67 Section 5.07. Adjustments to the Conversion Rate in Connection with a Make-Whole Fundamental Change 61 68 Section 5.08. Exchange in Lieu of Conversion 62 69 Section 5.09. Effect of Class A Common Stock Change Event 62 70 Article 6. Successors 64 72 Section 6.01. When the Company May Merge, Etc. 64 72 Section 6.02. Successor Entity Substituted 65 72 Section 6.03. Exclusion for Asset Transfers with Wholly Owned Subsidiaries 65 72 Article 7. Defaults and Remedies 65 73 Section 7.01. Events of Default 65 73 Section 7.02. Acceleration 67 75 Section 7.03. Sole Remedy for a Failure to Report 68 75 Section 7.04. Other Remedies 69 76 Section 7.05. Waiver of Past Defaults 69 77 Section 7.06. Cure of Defaults; Ability to Cure or Waive Before Event of Default Occurs 69 77 Section 7.07. Control by Majority 70 77 Section 7.08. Limitation on Suits 70 77 Section 7.09. Absolute Right of Holders to Institute Suit for the Enforcement of the Right to Receive Payment and Conversion Consideration 70 78 Section 7.10. Collection Suit by Trustee 71 78 Section 7.11. Trustee May File Proofs of Claim 71 78 Section 7.12. Priorities 71 79 Section 7.13. Undertaking for Costs 72 79 Article 8. Amendments, Supplements and Waivers 72 80 Section 8.01. Without the Consent of Holders 72 80 Section 8.02. With the Consent of Holders 73 81 Section 8.03. Notice of Amendments, Supplements and Waivers 74 82 Section 8.04. Revocation, Effect and Solicitation of Consents; Special Record Dates; Etc. 74 82 Section 8.05. Notations and Exchanges 75 83 Section 8.06. Trustee to Execute Supplemental Indentures 75 83 Article 9. Satisfaction and Discharge 75 83 Section 9.01. Termination of Company’s Obligations 75 83 Section 9.02. Repayment to Company 76 84 Section 9.03. Reinstatement 76 84 Article 10. Trustee 76 84 Section 10.01. Duties of the Trustee 76 84 Section 10.02. Rights of the Trustee 77 85 Section 10.03. Individual Rights of the Trustee 79 86 Section 10.04. Trustee’s Disclaimer 79 87 Section 10.05. Notice of Defaults 79 87 Section 10.06. Compensation and Indemnity 79 87 Section 10.07. Replacement of the Trustee 80 88 Section 10.08. Successor Trustee by Merger, Etc. 81 89 Section 10.09. Eligibility; Disqualification 81 89 Article 11. Miscellaneous 82 89 Section 11.01. Notices 82 89 Section 11.02. Delivery of Officer’s Certificate and Opinion of Counsel as to Conditions Precedent 83 91 Section 11.03. Statements Required in Officer’s Certificate and Opinion of Counsel 84 92 Section 11.04. Rules by the Trustee, the Registrar, the Paying Agent and the Conversion Agent 84 92 Section 11.05. No Personal Liability of Directors, Officers, Employees and Stockholders 84 92 Section 11.06. Governing Law; Waiver of Jury Trial 84 92 Section 11.07. Submission to Jurisdiction 85 93 Section 11.08. No Adverse Interpretation of Other Agreements 85 93 Section 11.09. Successors 85 93 Section 11.10. Force Majeure 85 93 Section 11.11. U.S.A. PATRIOT Act 85 93 Section 11.12. Calculations 85 94 Section 11.13. Severability 86 94 Section 11.14. Counterparts 86 94 Section 11.15. Table of Contents, Headings, Etc. 86 94 Section 11.16. Withholding Taxes 86 95 Exhibit A: Form of Note A-1 Exhibit B-1: Form of Restricted Note Legend B1-1 Exhibit B-2: Form of Global Note Legend B2-1 Exhibit B-3: Form of Non-Affiliate Legend B3-1 INDENTURE, dated as of May 13February 21, 2025, between Hims & Hers Health, Inc.MicroStrategy Incorporated, a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). Each party to this Indenture (as defined below) agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders (as defined below) of the Company’s 0.000% Convertible Senior Notes due 2030 (the “Notes”).
Appears in 1 contract
Sources: Indenture (MICROSTRATEGY Inc)
No Regular Interest; Accrual and Payment of Special Interest and Additional Interest. Defaulted Amounts; When Payment Date is Not a Business Day 17 Section 2.06. Registrar, Paying Agent and Conversion Agent 18 Section 2.07. Paying Agent and Conversion Agent to Hold Property in Trust 19 Section 2.08. Holder Lists 20 19 Section 2.09. Legends 20 19 Section 2.10. Transfers and Exchanges; Certain Transfer Restrictions 21 20 Section 2.11. Exchange and Cancellation of Notes to Be Converted or to Be Repurchased Pursuant to a Repurchase Upon Fundamental Change or Redemption 26 25 Section 2.12. Removal of Transfer Restrictions 26 Section 2.13. Replacement Notes 27 26 Section 2.132.14. Registered Holders; Certain Rights with Respect to Global Notes 27 Section 2.142.15. Cancellation 27 Section 2.152.16. Notes Held by the Company or its Affiliates 27 Section 2.162.17. Temporary Notes 28 27 Section 2.172.18. Outstanding Notes 28 Section 2.182.19. Repurchases by the Company 29 28 Section 2.192.20. ▇▇▇▇▇ and ISIN Numbers 29 Article 3. Covenants 29 Section 3.01. Payment on Notes 29 Section 3.02. Exchange Act Reports 29 Section 3.03. Rule 144A Information 30 Section 3.04. Additional Interest 30 Section 3.05. Compliance and Default Certificates 31 Section 3.06. Stay, Extension and Usury Laws 31 32 Section 3.07. Corporate Existence 32 Section 3.08. Acquisition of Notes by the Company and its Affiliates 32 Article 4. Repurchase and Redemption 32 Section 4.01. No Sinking Fund 32 Section 4.02. Right of Holders to Require the Company to Repurchase Notes Upon a Fundamental Change 32 Section 4.03. Right of the Company to Redeem the Notes 37 Article 5. The Conversion of Notes 40 Section 5.01. Right to Convert 40 Section 5.02. Conversion Procedures 44 Section 5.03. Settlement Upon Conversion 45 46 Section 5.04. Reserve and Status of Common Stock Issued Upon Conversion 49 Section 5.05. Adjustments to the Conversion Rate 50 Section 5.06. Voluntary Adjustments 60 Section 5.07. Adjustments to the Conversion Rate in Connection with a Make-Whole Fundamental Change 61 Section 5.08. Exchange in Lieu of Conversion 62 Section 5.09. Effect of Common Stock Change Event 62 63 Article 6. Successors 64 65 Section 6.01. When the Company May Merge, Etc. 64 65 Section 6.02. Successor Entity Substituted 65 Section 6.03. Exclusion for Asset Transfers with Wholly Owned Subsidiaries 65 Article 7. Defaults and Remedies 65 66 Section 7.01. Events of Default 65 66 Section 7.02. Acceleration 67 68 Section 7.03. Sole Remedy for a Failure to Report 68 Section 7.04. Other Remedies 69 Section 7.05. Waiver of Past Defaults 69 70 Section 7.06. Cure of Defaults; Ability to Cure or Waive Before Event of Default Occurs 69 70 Section 7.07. Control by Majority 70 Section 7.08. Limitation on Suits 70 71 Section 7.09. Absolute Right of Holders to Institute Suit for the Enforcement of the Right to Receive Payment and Conversion Consideration 70 71 Section 7.10. Collection Suit by Trustee 71 Section 7.11. Trustee May File Proofs of Claim 71 72 Section 7.12. Priorities 71 72 Section 7.13. Undertaking for Costs 72 73 Article 8. Amendments, Supplements and Waivers 72 73 Section 8.01. Without the Consent of Holders 72 73 Section 8.02. With the Consent of Holders 73 74 Section 8.03. Notice of Amendments, Supplements and Waivers 74 75 Section 8.04. Revocation, Effect and Solicitation of Consents; Special Record Dates; Etc. 74 75 Section 8.05. Notations and Exchanges 75 76 Section 8.06. Trustee to Execute Supplemental Indentures 75 76 Article 9. Satisfaction and Discharge 75 76 Section 9.01. Termination of Company’s Obligations 75 76 Section 9.02. Repayment to Company 76 77 Section 9.03. Reinstatement 76 77 Article 10. Trustee 76 77 Section 10.01. Duties of the Trustee 76 77 Section 10.02. Rights of the Trustee 77 79 Section 10.03. Individual Rights of the Trustee 79 80 Section 10.04. Trustee’s Disclaimer 79 80 Section 10.05. Notice of Defaults 79 80 Section 10.06. Compensation and Indemnity 79 81 Section 10.07. Replacement of the Trustee 80 82 Section 10.08. Successor Trustee by Merger, Etc. 81 82 Section 10.09. Eligibility; Disqualification 81 83 Article 11. Miscellaneous 82 83 Section 11.01. Notices 82 83 Section 11.02. Delivery of Officer’s Certificate and Opinion of Counsel as to Conditions Precedent 83 85 Section 11.03. Statements Required in Officer’s Certificate and Opinion of Counsel 84 85 Section 11.04. Rules by the Trustee, the Registrar, the Paying Agent and the Conversion Agent 84 86 Section 11.05. No Personal Liability of Directors, Officers, Employees and Stockholders 84 86 Section 11.06. Governing Law; Waiver of Jury Trial 84 86 Section 11.07. Submission to Jurisdiction 85 86 Section 11.08. No Adverse Interpretation of Other Agreements 85 86 Section 11.09. Successors 85 87 Section 11.10. Force Majeure 85 87 Section 11.11. U.S.A. PATRIOT Act 85 87 Section 11.12. Calculations 85 87 Section 11.13. Severability 86 87 Section 11.14. Counterparts 86 88 Section 11.15. Table of Contents, Headings, Etc. 86 88 Section 11.16. Withholding Taxes 86 88 Exhibit A: Form of Note A-1 Exhibit B-1: Form of Restricted Note Legend B1-1 Exhibit B-2: Form of Global Note Legend B2-1 Exhibit B-3: Form of Non-Affiliate Resale Legend B3-1 INDENTURE, dated as of May 13August 14, 2025, between Hims & Hers HealthDigitalOcean Holdings, Inc., a Delaware corporation, as issuer (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”). Each party to this Indenture (as defined below) agrees as follows for the benefit of the other party and for the equal and ratable benefit of the Holders (as defined below) of the Company’s 0.00% Convertible Senior Notes due 2030 (the “Notes”).
Appears in 1 contract